Keyphrases
Cytomegalovirus Infection
100%
Post-transplantation Cyclophosphamide (PTCy)
100%
CIBMTR
100%
Hazard Ratio
23%
Graft-versus-host Disease (GvHD)
23%
Serostatus
15%
Allograft
7%
Overall Survival
7%
Prevention Strategies
7%
Seropositivity
7%
Cytomegalovirus
7%
Study Support
7%
Marrow Transplantation
7%
High Incidence
7%
Cytomegalovirus Disease
7%
Infection Risk
7%
Haploidentical Transplantation
7%
Cumulative Incidence
7%
Transplant Outcomes
7%
Calcineurin Inhibitors
7%
Matched Related
7%
Graft Source
7%
Non-relapse Mortality
7%
Disease Protection
7%
Medicine and Dentistry
Cyclophosphamide
100%
Cytomegalovirus Infection
100%
Hazard Ratio
21%
Chronic Graft Versus Host Disease
21%
Transplantation
7%
Allograft
7%
Overall Survival
7%
Cytomegalovirus
7%
Calcineurin Inhibitor
7%
Cumulative Incidence
7%
Transplantation Research
7%
Immunology and Microbiology
Cytomegalovirus Infection
100%
Cyclophosphamide
100%
Chronic Graft Versus Host Disease
23%
Cytomegalovirus
15%
Allograft
7%
Seropositivity
7%
Overall Survival
7%
Transplantation Research
7%